Passage Bio, Inc. (PASG)

Passage Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	37.57	21.71	34.6	128.97	135
Short-Term Investments	39.18	92.59	155.01	186.81	169.82
Cash & Short-Term Investments	76.76	114.29	189.61	315.77	304.82
Cash Growth	-32.84%	-39.72%	-39.95%	3.59%	91.86%
Prepaid Expenses	0.84	0.92	0.93	1.73	1.41
Other Current Assets	1.22	2.74	6.51	7.57	10.96
Total Current Assets	78.82	117.96	197.04	325.07	317.18
Property, Plant & Equipment	23.13	32.15	42.24	23.81	2.8
Other Long-Term Assets	0.46	0.43	4.27	6.2	8.03
Total Assets	102.41	150.55	243.55	355.08	328.01
Accounts Payable	0.74	1.3	4.07	9.45	5.27
Accrued Expenses	6.71	9.67	10.93	19.39	15.37
Current Portion of Leases	3.69	3.37	3.28	-	-
Other Current Liabilities	8.23	2	0.09	0.66	0.54
Total Current Liabilities	19.36	16.34	18.35	29.5	21.18
Long-Term Leases	21.79	22.92	23.83	-	-
Other Long-Term Liabilities	-	-	-	6.92	2.12
Total Liabilities	41.15	39.26	42.18	36.42	23.29
Common Stock	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	720.48	705.79	694.73	675.35	475.62
Retained Earnings	-659.24	-594.47	-492.41	-356.28	-170.9
Comprehensive Income & Other	0.01	-0.04	-0.97	-0.41	-0.01
Total Common Equity	61.26	111.28	201.37	318.66	304.71
Shareholders' Equity	61.26	111.28	201.37	318.66	304.71
Total Liabilities & Equity	102.41	150.55	243.55	355.08	328.01
Total Debt	25.48	26.29	27.11	-	-
Net Cash (Debt)	51.28	88	162.5	315.77	304.82
Net Cash Growth	-41.73%	-45.85%	-48.54%	3.59%	91.86%
Net Cash Per Share	0.85	1.61	2.99	5.92	7.89
Filing Date Shares Outstanding	62.15	55.6	54.62	54.29	53.83
Total Common Shares Outstanding	62.06	54.94	54.61	54.24	45.61
Working Capital	59.45	101.62	178.69	295.57	296.01
Book Value Per Share	0.99	2.03	3.69	5.87	6.68
Tangible Book Value	61.26	111.28	201.37	318.66	304.71
Tangible Book Value Per Share	0.99	2.03	3.69	5.87	6.68
Machinery	11.67	11.68	12.87	12.05	0.78
Construction In Progress	-	0.64	1.29	0.82	1.31
Leasehold Improvements	7.39	10.21	13.51	13.41	1.64

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q